Literature DB >> 17312987

Outside-hospital assistance for children and adolescents with type 1 diabetes mellitus.

Maurizio Vanelli1, Matteo Corchia, Brunella Iovane, Chiara Gelmetti, Alessandra Mele, Silvia La Cava, Giovanni Chiari.   

Abstract

Telephone care, Telemedicine, Home care and Diabetic Camps are the most useful ways for Paediatricians to transfer diabetic care outside the hospital. These provide children with diabetes and their parents with an effective and practical tool to solve directly arising therapeutic problems and improve their quality of care and life. The advantages for the National Health Care System could be macroscopic: according to some studies, the Telephone care service allows to save 85% of the hospitalisation costs for children with acute metabolic intercurrent illnesses-related derangements. Telemedicine service, based on telephone line relying on the Internet technology, is a complementary tool to follow children and adolescents with diabetes in out-patient clinic. The rare experiences in this field report a reduction in insulin doses and an improvement of metabolic control and quality of life. The Home care service has to be performed by a nurse and has to be useful for patients and parents to organize the management of diabetes at home and to improve therapeutic adherence. Diabetic camps give the opportunity to children and adolescents with diabetes to verify, outside the family and under health professionals' supervision, their ability to manage the disease, and to increase own self-esteem.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17312987

Source DB:  PubMed          Journal:  Acta Biomed        ISSN: 0392-4203


  2 in total

1.  Technology Use for Problem Solving in Adolescent Type 1 Diabetes.

Authors:  Ling Hinshaw; Ananda Basu
Journal:  Diabetes Technol Ther       Date:  2015-07       Impact factor: 6.118

2.  Psycho-behavioral changes in children with type 1 diabetes mellitus.

Authors:  Xiao-Ping Zheng; Shuo-Hui Chen
Journal:  World J Pediatr       Date:  2013-08-09       Impact factor: 2.764

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.